title: Lipohypertrophy and glomerulonephritis after the use of aprotinin in an insulin-dependent diabetic.
authors.forename: F
authors.initials: F
authors.lastname: Boag
authors.forename: M
authors.initials: M
authors.lastname: Chappell
authors.forename: A G
authors.initials: AG
authors.lastname: Beckett
authors.forename: P
authors.initials: P
authors.lastname: Dandona
mesh_terms: D000273:Adipose Tissue / Q000473:pathology*; D000293:Adolescent; D007611:Aprotinin / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D005921:Glomerulonephritis / Q000139:chemically induced*; D006801:Humans; D006984:Hypertrophy; D007333:Insulin Resistance
chemical_list: D007611:Aprotinin